Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
The New England Journal of Medicine
|
February 2, 2022
Efficacy and Safety of Gene Therapy for β-Thalassemia
Emmanuel Payen
Hematology. American Society of Hematology. Education Program
|
December 13, 2012
Advances in stem cell transplantation and gene therapy in the β-hemoglobinopathies
Emmanuel Payen, Philippe Leboulch
Biomedical Journal
|
April 24, 2016
Current and future alternative therapies for beta-thalassemia major
Edouard de Dreuzy, Kanit Bhukhai, Philippe Leboulch, et al.
Experimental Hematology
|
May 29, 2018
Hemoglobin disorders: lentiviral gene therapy in the starting blocks to enter clinical practice
Karine Sii-Felice, Marie Giorgi, Philippe Leboulch, et al.
Genetic Vaccines and Therapy
|
March 13, 2008
Careful adjustment of Epo non-viral gene therapy for beta-thalassemic anaemia treatment
Emmanuelle E Fabre, Pascal Bigey, Yves Beuzard, et al.
Methods in Enzymology
|
February 28, 2012
Lentivirus vectors in β-thalassemia
Emmanuel Payen, Charlotte Colomb, Olivier Negre, et al.
Viruses
|
December 23, 2020
Enhanced Cell-Based Detection of Parvovirus B19V Infectious Units According to Cell Cycle Status
Céline Ducloux, Bruno You, Amandine Langelé, et al.
Experimental Hematology
|
February 26, 2008
Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin
Olivier Negre, Floriane Fusil, Annie Henri, et al.
Stem Cells (Dayton, Ohio)
|
April 5, 2013
Arrayed lentiviral barcoding for quantification analysis of hematopoietic dynamics
Jeanne Grosselin, Karine Sii-Felice, Emmanuel Payen, et al.
Blood
|
February 10, 2011
Is normal hematopoiesis maintained solely by long-term multipotent stem cells?
Marina Cavazzana-Calvo, Alain Fischer, Frederic D Bushman, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
The New England Journal of Medicine
|
February 2, 2022
Efficacy and Safety of Gene Therapy for β-Thalassemia
Emmanuel Payen
Hematology. American Society of Hematology. Education Program
|
December 13, 2012
Advances in stem cell transplantation and gene therapy in the β-hemoglobinopathies
Emmanuel Payen, Philippe Leboulch
Biomedical Journal
|
April 24, 2016
Current and future alternative therapies for beta-thalassemia major
Edouard de Dreuzy, Kanit Bhukhai, Philippe Leboulch, et al.
Experimental Hematology
|
May 29, 2018
Hemoglobin disorders: lentiviral gene therapy in the starting blocks to enter clinical practice
Karine Sii-Felice, Marie Giorgi, Philippe Leboulch, et al.
Genetic Vaccines and Therapy
|
March 13, 2008
Careful adjustment of Epo non-viral gene therapy for beta-thalassemic anaemia treatment
Emmanuelle E Fabre, Pascal Bigey, Yves Beuzard, et al.
Methods in Enzymology
|
February 28, 2012
Lentivirus vectors in β-thalassemia
Emmanuel Payen, Charlotte Colomb, Olivier Negre, et al.
Viruses
|
December 23, 2020
Enhanced Cell-Based Detection of Parvovirus B19V Infectious Units According to Cell Cycle Status
Céline Ducloux, Bruno You, Amandine Langelé, et al.
Experimental Hematology
|
February 26, 2008
Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin
Olivier Negre, Floriane Fusil, Annie Henri, et al.
Stem Cells (Dayton, Ohio)
|
April 5, 2013
Arrayed lentiviral barcoding for quantification analysis of hematopoietic dynamics
Jeanne Grosselin, Karine Sii-Felice, Emmanuel Payen, et al.
Blood
|
February 10, 2011
Is normal hematopoiesis maintained solely by long-term multipotent stem cells?
Marina Cavazzana-Calvo, Alain Fischer, Frederic D Bushman, et al.
Page
of 4